[Federal Register Volume 89, Number 138 (Thursday, July 18, 2024)]
[Notices]
[Page 58377]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15793]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Board of Scientific Counselors, National Center 
for Injury Prevention and Control

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting for the Board of Scientific Counselors, National 
Center for Injury Prevention and Control (BSC, NCIPC). This meeting is 
open to the public. Time will be available for public comment.

DATES: The meeting will be held on September 24, 2024, from 10 a.m. to 
12:30 p.m., EDT. The public comment period will be from 12:10 p.m. to 
12:25 p.m., EDT.

ADDRESSES: Webinar, Atlanta, Georgia. All participants must register by 
using the following link to attend the meeting: https://cdc.zoomgov.com/webinar/register/WN_cnG74hSRR8C_2DCCRmW5Hg.

FOR FURTHER INFORMATION CONTACT: Christopher R. Harper, Ph.D., 
Designated Federal Officer, Board of Scientific Counselors, National 
Center for Injury Prevention and Control, Centers for Disease Control 
and Prevention, 4770 Buford Highway NE, Mailstop S-1069, Atlanta, 
Georgia 30341. Telephone: (404) 718-8330; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Board of Scientific Counselors, National Center for 
Injury Prevention and Control (BSC, NCIPC) will: (1) conduct, 
encourage, cooperate with, and assist other appropriate public health 
authorities, scientific institutions, and scientists in the conduct of 
research, investigations, experiments, demonstrations, and studies 
relating to the causes and strategies related to the prevention of 
injury, overdose, and violence; (2) assist States and other entities in 
preventing intentional and unintentional injuries, and to promote 
health and well-being; and (3) make recommendations of grants and 
cooperative agreements for research and prevention activities related 
to injury, overdose, and violence. The BSC, NCIPC makes recommendations 
regarding policies, strategies, objectives, and priorities and reviews 
progress toward injury, overdose, and violence prevention. The Board 
also provides advice on the appropriate balance of intramural and 
extramural research and provides guidance on the needs, structure, 
progress, and performance of intramural programs. Further, the Board 
provides guidance on extramural scientific program matters. 
Additionally, the Board provides second-level scientific and 
programmatic review of applications for research grants, cooperative 
agreements, and training grants related to injury, overdose, and 
violence prevention, and recommends approval of projects that merit 
further consideration for funding support. The Board also provides 
feedback and input on strategic plans, resources, and priority 
publications related to injury, overdose, and violence prevention.
    Matters to be Considered: The agenda will include discussions on 
the Updated Child Abuse and Neglect Research Priorities and the Updated 
Youth and Community Violence Research Priorities. Agenda items are 
subject to change as priorities dictate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-15793 Filed 7-17-24; 8:45 am]
BILLING CODE 4163-18-P